For nearly 8 years, the JAMA Forum has been providing expert commentary and insight into news that involves the intersection of health policy and politics, economics, and the law from a team of leading scholars, including health economists, experts in… Read More ›
Among all global health initiatives—such as the Global Polio Eradication Initiative, Roll Back Malaria (the RBM Partnership to End Malaria), and the Stop TB Partnership—universal health coverage (often abbreviated as UHC) has garnered the most political attention. The “sustainable development… Read More ›
By Dhruv Khullar, MD, MPP, and Dave A. Chokshi, MD, MSc Since the English physician John Snow first mapped London’s cholera outbreak to a local water pump in the 1850s, it has been understood that a community’s design affects the… Read More ›
More than 50 years ago, H. Jack Geiger, MD, and community organizer John Hatch built a community health center in the Mississippi Delta with funding from the Office of Economic Opportunity, a federal program established by President Lyndon B. Johnson… Read More ›
The growing interest in addressing social determinants of health—nonclinical factors influencing health—raises practical issues about the way we budget for collaborative efforts across governmental departments. In particular, the expanding research on the relationship between such factors as housing, transportation, and… Read More ›
The era of precision medicine has arrived. A large share of new pharmaceuticals are tested and approved on the basis of biomarkers. Pharmacogenetics—the tailoring of drugs to patients based on 1 or more biomarkers—is used in conditions as diverse as… Read More ›
Between now and the November 2020 election, Democrats and Republicans are unlikely to pass any legislation other than budget bills or other “must-pass” legislation. The sharpened rhetoric and hyperbole associated with the impeachment hearings taking place in the House are… Read More ›
With a staggering amount of waste, as documented in the recent JAMA study, a key question is whether our health care system can produce the same or better outcomes for less money—in other words, can it become more productive or… Read More ›
As “Medicare for all” gains steam in the Democratic primary, many physicians are concerned about reduced revenues from the program compared with private insurance. Even an expansion of the program, as many candidates’ plans call for “Medicare for more,” causes… Read More ›
Twenty years ago, any path to improving health care in the United States began and ended with Congress. In today’s world, that no longer suffices. Thankfully, it doesn’t have to. Congress has stepped up to many challenges over the years…. Read More ›
